Atlas Brown’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.95M | Sell |
80,876
-217
| -0.3% | -$5.68K | 0.52% | 46 |
|
|
2026
Q1 | $2.28M | Buy |
81,093
+566
| +0.7% | +$15.1K | 0.69% | 38 |
|
|
2025
Q4 | $2.01M | Buy |
80,527
+2,057
| +3% | +$51.9K | 0.6% | 47 |
|
|
2025
Q3 | $2M | Sell |
78,470
-1,262
| -2% | -$31.1K | 0.59% | 44 |
|
|
2025
Q2 | $1.93M | Buy |
79,732
+2,929
| +4% | +$68.3K | 0.62% | 44 |
|
|
2025
Q1 | $1.95M | Buy |
76,803
+3,886
| +5% | +$102K | 0.68% | 35 |
|
|
2024
Q4 | $1.93M | Buy |
72,917
+2,701
| +4% | +$73.3K | 0.66% | 38 |
|
|
2024
Q3 | $2.03M | Sell |
70,216
-1,534
| -2% | -$44.7K | 0.7% | 34 |
|
|
2024
Q2 | $2.01M | Buy |
71,750
+1,568
| +2% | +$43.2K | 0.72% | 37 |
|
|
2024
Q1 | $1.95M | Buy |
70,182
+3,236
| +5% | +$89.8K | 0.71% | 38 |
|
|
2023
Q4 | $1.93M | Sell |
66,946
-3,903
| -6% | -$118K | 0.8% | 37 |
|
|
2023
Q3 | $2.35M | Buy |
70,849
+875
| +1% | +$30.9K | 1.07% | 23 |
|
|
2023
Q2 | $2.57M | Buy |
69,974
+887
| +1% | +$34.5K | 1.13% | 21 |
|
|
2023
Q1 | $2.82M | Buy |
69,087
+2,684
| +4% | +$116K | 1.3% | 17 |
|
|
2022
Q4 | $3.4M | Sell |
66,403
-4,453
| -6% | -$213K | 1.67% | 12 |
|
|
2022
Q3 | $3.1M | Buy |
70,856
+901
| +1% | +$43.8K | 1.58% | 13 |
|
|
2022
Q2 | $3.67M | Buy |
69,955
+443
| +0.6% | +$22.6K | 1.73% | 11 |
|
|
2022
Q1 | $3.6M | Buy |
69,512
+3,820
| +6% | +$198K | 1.47% | 16 |
|
|
2021
Q4 | $3.88M | Sell |
65,692
-557
| -0.8% | -$27.6K | 1.5% | 15 |
|
|
2021
Q3 | $2.85M | Buy |
66,249
+795
| +1% | +$35.2K | 1.24% | 22 |
|
|
2021
Q2 | $2.56M | Buy |
65,454
+5,361
| +9% | +$208K | 1.11% | 25 |
|
|
2021
Q1 | $2.18M | Buy |
60,093
+5,370
| +10% | +$191K | 1.03% | 30 |
|
|
2020
Q4 | $2.01M | Sell |
54,723
-1,186
| -2% | -$43.5K | 1.04% | 28 |
|
|
2020
Q3 | $1.95M | Buy |
55,909
+615
| +1% | +$21.6K | 1.15% | 27 |
|
|
2020
Q2 | $1.72M | Sell |
55,294
-153
| -0.3% | -$5.2K | 1.09% | 30 |
|
|
2020
Q1 | $1.72M | Buy |
55,447
+3,094
| +6% | +$105K | 1.34% | 19 |
|
|
2019
Q4 | $1.95M | Buy |
52,353
+3,524
| +7% | +$126K | 1.22% | 27 |
|
|
2019
Q3 | $1.67M | Sell |
48,829
-1,689
| -3% | -$61.4K | 1.19% | 26 |
|
|
2019
Q2 | $2.08M | Buy |
50,518
+402
| +0.8% | +$16K | 1.43% | 17 |
|
|
2019
Q1 | $2.02M | Sell |
50,116
-1,973
| -4% | -$79K | 1.43% | 18 |
|
|
2018
Q4 | $2.16M | Buy |
52,089
+1,297
| +3% | +$53.8K | 1.66% | 15 |
|
|
2018
Q3 | $2.12M | Sell |
50,792
-3,905
| -7% | -$150K | 1.3% | 17 |
|
|
2018
Q2 | $1.94M | Buy |
54,697
+169
| +0.3% | +$5.78K | 0.45% | 23 |
|
|
2018
Q1 | $1.84M | Buy |
54,528
+2,503
| +5% | +$86K | 0.33% | 23 |
|
|
2017
Q4 | $1.82M | Buy |
52,025
+790
| +2% | +$26.9K | 0.33% | 26 |
|
|
2017
Q3 | $1.74M | Buy |
51,235
+14,517
| +40% | +$467K | 0.37% | 25 |
|
|
2017
Q2 | $1.17M | Sell |
36,718
-668
| -2% | -$21.1K | 1.02% | 33 |
|
|
2017
Q1 | $1.21M | Buy |
37,386
+4,317
| +13% | +$136K | 0.96% | 32 |
|
|
2016
Q4 | $1.06M | Hold |
33,069
| – | – | 0.44% | 34 |
|
|
2016
Q3 | $1.06M | Sell |
33,069
-709
| -2% | -$23.7K | 0.44% | 34 |
|
|
2016
Q2 | $1.13M | Buy |
33,778
+2,548
| +8% | +$81.3K | 0.46% | 33 |
|
|
2016
Q1 | $878K | Buy |
31,230
+583
| +2% | +$16.7K | 0.37% | 40 |
|
|
2015
Q4 | $887K | Sell |
30,647
-564
| -2% | -$17.7K | 0.56% | 35 |
|
|
2015
Q3 | $930K | Buy |
31,211
+87
| +0.3% | +$2.79K | 0.4% | 35 |
|
|
2015
Q2 | $1.04M | Buy |
31,124
+1,013
| +3% | +$33K | 0.41% | 36 |
|
|
2015
Q1 | $994K | Buy |
30,111
+49
| +0.2% | +$1.56K | 0.27% | 36 |
|
|
2014
Q4 | $888K | Buy |
30,062
+1,008
| +3% | +$28.9K | 0.24% | 41 |
|
|
2014
Q3 | $815K | Sell |
29,054
-130
| -0.4% | -$3.65K | 0.3% | 41 |
|
|
2014
Q2 | $822K | Buy |
29,184
+652
| +2% | +$18.6K | 0.41% | 36 |
|
|
2014
Q1 | $869K | Buy |
28,532
+459
| +2% | +$13.7K | 0.47% | 33 |
|
|
2013
Q4 | $816K | Buy |
28,073
+207
| +0.7% | +$6.03K | 0.57% | 22 |
|
|
2013
Q3 | $759K | Sell |
27,866
-2,188
| -7% | -$59.5K | 0.57% | 25 |
|
|
2013
Q2 | $799K | Buy |
+30,054
| New | +$830K | 0.17% | 64 |
|
Other funds holding PFE
Atlas Brown's PFE Position: Q2 2026 in Review
Atlas Brown reduced its Pfizer (PFE) stake by 0.27% in Q2 2026, selling an estimated $5.68K and leaving 80,876 shares worth $1.95M. The position accounts for 0.52% of the portfolio, ranked #46.
Atlas Brown first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.88M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Atlas Brown held 80,876 shares of Pfizer worth $1.95M as of Q2 2026.
- Atlas Brown sold 217 Pfizer shares in Q2 2026, an estimated $5.68K.
- Pfizer made up 0.52% of Atlas Brown's portfolio in Q2 2026, its #46 holding.
- Atlas Brown first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Atlas Brown's Pfizer position peaked at $3.88M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Atlas Brown's 13F filing for Q2 2026, filed 9 Jul 2026.